Acetylcysteine + vitamin D

Intervention

1 paper1 finding

  • 1 lab in 1 country
  • Human trial1

Outcomes

1

CDKN2A

downin humans1

1 study
  1. Acetylcysteine + vitamin D decreases CDKN2A in humans.

    “co-administration of NAC with 1000 IU of Vit-D significantly downregulated p16 transcripts in PBMCs compared to Vit-D 1000 IU alone.”

    Human trialvitamin D deficiencyPBMCs1000 IU Vit-D plus 600 mg of NAC daily vs 1000 IU Vit-D daily8 weeks

    Co-administration of vitamin D and N-acetylcysteine to modulate immunosenescence in older adults with vitamin D deficiency: a randomized clinical trial

    Frontiers in immunology12 May 2025

More on CDKN2A

Latest